Citation
(2007), "Epax confirms its oils used in Alzheimer's study", Nutrition & Food Science, Vol. 37 No. 6. https://doi.org/10.1108/nfs.2007.01737fab.048
Publisher
:Emerald Group Publishing Limited
Copyright © 2007, Emerald Group Publishing Limited
Epax confirms its oils used in Alzheimer's study
Epax confirms its oils used in Alzheimer's study
Clinical trial shows omega-3 fatty acids help combat depression and agitation symptoms associated with the disease.
Omega-3 fatty acids were again proven to help serious symptoms coinciding with the memory decline characteristic for Alzheimer's disease, according to a recent study conducted by Yvonne Freund-Levi, MD from Sweden's Karolinska Institute. EPAX AS, a world-leading supplier of highly concentrated omega-3 EPA/DHA fatty acids, confirmed its EPAX 1050 TG oil was used in the study.
Recently published in the International Journal of Geriatric Psychiatry, Freund-Levi's study was a randomised, double-blind, placebo-controlled clinical trial. It showed that carriers of a specific gene common to those with Alzheimer's disease who received the omega-3 supplements responded positively to the omega-3s with regard to agitation symptoms. Those without the gene showed an improvement in symptoms of depression.
"These findings are surely encouraging to the millions of people affected by Alzheimer's disease. This study helps demonstrate the many positive impacts of omega-3 fatty acids, whether one has specific health concerns or is simply looking to stay healthy. We are pleased that EPAX could play a role in this impressive clinical trial", said Bjorn Refsum, CEO of EPAX AS.
A previous study, published in the October 2006 issues of Archives of Neurology, conducted by Freund-Levi found that patients with early stage Alzheimer's disease given EPAX 1050 TG omega-3 fatty acids showed significant improvement in memory decline compared to the control group.
EPAX 1050 TG is specially formulated for cognitive health. All of EPAX's oils are indication-specific and in addition to cognitive health, oils are available to address cardiovascular health, mood and mind health, joint health, pre-and post-natal health and weight management.
For further information on EPAX AS, its products or clinical studies visit: www.epax.com